Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune Activation.
Moquist PN, Zhang X, Leiske CI, Eng-Duncan NM, Zeng W, Bindman NA, Wo SW, Wong A, Henderson CM, Crowder K, Lyon R, Doronina SO, Senter PD, Neff-LaFord HD, Sussman D, Gardai SJ, Levengood MR.
Moquist PN, et al. Among authors: lyon r.
Bioconjug Chem. 2024 May 24. doi: 10.1021/acs.bioconjchem.4c00212. Online ahead of print.
Bioconjug Chem. 2024.
PMID: 38789102